Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 12/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | HTR6 | P50406 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14377101 | 0.88 | MAPT (0.57) | MAPTALDH1A1SMN1; SMN2MAPK1RECQL | |
| SCHEMBL7800552 | 0.86 | ALDH1A1 (0.69) | MAPTALDH1A1SMN1; SMN2MAPK1LMNA | |
| SCHEMBL7809589 | 0.84 | ALDH1A1 (0.68) | MAPTALDH1A1SMN1; SMN2MAPK1LMNA | |
| SCHEMBL3537059 | 0.84 | ALDH1A1 (0.68) | MAPTALDH1A1SMN1; SMN2MAPK1LMNA | |
| SCHEMBL6663094 | 0.83 | MAPT (0.66) | MAPTALDH1A1SMN1; SMN2MAPK1RECQL | |
| SCHEMBL14941307 | 0.82 | LMNA (0.75) | MAPTALDH1A1SMN1; SMN2MAPK1RECQL | |
| SCHEMBL15016552 | 0.82 | ALDH1A1 (0.64) | MAPTALDH1A1SMN1; SMN2LMNACYP1A2 | |
| SCHEMBL7809569 | 0.82 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2MAPK1LMNA | |
| SCHEMBL5552187 | 0.82 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2MAPK1RECQL | |
| SCHEMBL14940749 | 0.82 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2MAPK1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010052156-A1 | DYES | HANS SCHWARZKOPF GMBH & CO. KG (DE) | 2001-12-20 | — | — | US | disclosed |
| US-20010005914-A1 | OXIDATION DYES | ANDREAS J. BITTNER | 2001-07-05 | — | — | US | disclosed |
| EP-0912160-A2 | OXIDATION DYES | Hans Schwarzkopf GmbH & Co. KG (DE) | 1999-05-06 | — | — | EP | disclosed |
| EP-0910332-A2 | DYES | Hans Schwarzkopf GmbH & Co. KG (DE) | 1999-04-28 | — | — | EP | disclosed |
| WO-1998001106-A2 | OXIDATION DYES | HANS SCHWARZKOPF GMBH & CO. KG (DE) | 1998-01-15 | — | — | WO | disclosed |
| WO-1998001105-A2 | DYES | HANS SCHWARZKOPF GMBH & CO. KG (DE) | 1998-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010052156-A1 | DYES | KRT18, OPRD1, HTR1D | MAPT 4151/4885ALDH1A1 86/4885SMN1; SMN2 3957/4885 |
| US-20010005914-A1 | OXIDATION DYES | AOC1, CBR3, KRT18 | MAPT 3633/4885ALDH1A1 26/4885SMN1; SMN2 4199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.